Ozempic maker struggles as it loses ground to rivals in weight-loss market
Novo Nordisk cuts sales and profit forecasts as it continues to lose ground to Mounjaro firm Eli Lilly The maker of Ozempic and Wegovy has cut its sales and profit forecasts as it continues to fall behind in the competitive market for obesity and diabetes treatments. Novo Nordisk’s chief (…)
Site référencé:
The Guardian (South&CentralAsia)
2847.jpg?width=140&quality=85&auto=format&fit=max&s=6294b6e1775d2a17950bf012b978e85a, 2847.jpg?width=460&quality=85&auto=format&fit=max&s=8d07e42f8ba690d3879851340f11f6eb, 2847.jpg?width=700&quality=85&auto=format&fit=max&s=0e2d0a82e6ad2e53e2b962b0aa290d0a
The Guardian (South&CentralAsia)
The Zohran Mamdani method can work beyond New York. Take the fight to the right | Aditya Chakrabortty
5/11/2025
David Lammy under pressure as two more prisoners mistakenly freed
5/11/2025
McIlroy thanks PGA chief for Ryder Cup apology and questions LIV changes
5/11/2025
‘A model of the transnational artist’ : Cuban artist Wifredo Lam gets first US retrospective
5/11/2025
Miss Piggy movie on way from Jennifer Lawrence, Emma Stone and Cole Escola
5/11/2025
Experts call for new taxes on worst polluters to help poorer nations with climate crisis
5/11/2025